MarketInOut Stock Screener Log In | Sign Up

ACADIA Pharmaceuticals Inc

IEX • Healthcare • Biotechnology • Quote as of 11/17/2026 15:59
ACADIA Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization3,240.54 mln
Float170 mln
Earnings Date03/01/2027

EPS

2.12
Solid

P / E

8.63
Undervalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.24
Manipulation likely

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

Business Description

ACADIA Pharmaceuticals is a US-based drug development company focused on treating neurological and rare diseases. Its two approved products, NUPLAZID and DAYBUE, address psychosis in Parkinson's disease and symptoms of Rett syndrome respectively. The company has several additional treatments in various stages of clinical trials, targeting conditions such as Alzheimer's disease psychosis, major depressive disorder, essential tremor, and Huntington's disease. Founded in 1993 and based in San Diego, California, ACADIA also works with partners like Neuren Pharmaceuticals and Stoke Therapeutics to expand its pipeline of specialized medicines.

Key Fundamentals

EPS2.12
P/E8.63
ROE29.76
RPS7.03
ROIC23.08
ROA22.53
EBITDA, mln166
EV / EBITDA16.33
EV / EBIT17.27
Revenue, mln1,202
EV / Revenue2.26

Quote Details

Last 18.31
Change -0.37 (-1.98%)
Open 18.54
Volume 1,141,173
Turnover 20,894,878
Average Volume 2,199,580

Financial Ratios

Pre-Tax Profit Margin13
Leverage Ratio1.29
Current Ratio3.82
Price / Book2.67
Price / Tangible Book2.95
Price / Cash Flow24.60
Price / Free Cash Flow24.94
Debt / Equity0.04
Price / Sales3.04
PEG Ratio50.86

Financial Strength

Altman Z-Score5.08
Piotroski F-Score 5 / 9
Beneish M-Score-1.24
Price to Intrinsic Value3.01
Price to Graham Number1.15
Short Ratio4.69
Short % of Float7.59

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.16% 87 / 100   
1 Month -7.53% 32 / 100   
2 Months -37.83% 12 / 100   
6 Months -10.6% 32 / 100   
1 Year -23.77% 28 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog